Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
1.
Rev Med Interne ; 42(6): 401-410, 2021 Jun.
Article in French | MEDLINE | ID: covidwho-1258490

ABSTRACT

Viral infections may involve all ocular tissues and may have short and long-term sight-threatening consequences. Among them, ocular infections caused by herpesviruses are the most frequent. HSV-1 keratitis and kerato-uveitis affect approximately are the leading cause of infectious blindness in the Western world, mainly because of corneal opacification caused by recurrences. For this reason, they may warrant long-term antiviral prophylaxis. Herpes zoster ophthalmicus, accounts for 10 to 20% of all shingles locations and can be associated with severe ocular involvement (keratitis, kerato-uveitis) of which a quarter becomes chronic/recurrent. Post herpetic neuralgias in the trigeminal territory can be particularly debilitating. Necrotizing retinitis caused by herpesviruses (HSV, VZV, CMV) are seldom, but must be considered as absolute visual emergencies, requiring urgent intravenous and intravitreal antiviral treatment. Clinical pictures depend on the immune status of the host. Adenovirus are the most frequent cause of infectious conjunctivitis. These most often benign infections are highly contagious and may be complicated by visually disabling corneal lesions that may last over months or years. Some arboviruses may be associated with inflammatory ocular manifestations. Among them, congenital Zika infections may cause macular or optic atrophy. Conjunctivitis is frequent during the acute phase of Ebola virus disease. Up to 15% of survivors present with severe chronic inflammatory ocular conditions caused by viral persistence in uveal tissues. Finally, COVID-19-associated conjunctivitis can precede systemic disease, or even be the unique manifestation of the disease. Utmost caution must be taken because of viral shedding in tears.


Subject(s)
Eye Infections, Viral/complications , COVID-19/complications , Conjunctivitis, Viral/virology , Cytomegalovirus Retinitis/complications , Eye Infections, Viral/prevention & control , Hemorrhagic Fever, Ebola/complications , Herpes Zoster Ophthalmicus/epidemiology , Herpes Zoster Ophthalmicus/prevention & control , Humans , Immunocompetence , Immunocompromised Host , Neuralgia, Postherpetic/etiology , Retinitis/drug therapy , Retinitis/virology , Trigeminal Nerve Diseases/complications , Trigeminal Nerve Diseases/virology , Zika Virus Infection/complications
3.
Ocul Immunol Inflamm ; 29(4): 677-680, 2021 May 19.
Article in English | MEDLINE | ID: covidwho-1172599

ABSTRACT

Purpose: Herein, we report a case of bilateral neuroretinitis and panuveitis in a patient recovered from coronavirus disease 2019 (COVID-19).Case presentation: A 37-year-old male patient with a history of recovered COVID-19, which was confirmed with nasopharyngeal reverse transcriptase polymerase chain reaction (RT-PCR) for Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), about one-month ago was referred with one-week history of bilateral severe vision loss. Visual acuity was counting fingers, and bilateral retinitis and panuveitis were revealed in ocular examination. The result of the vitreous sample using RT-PCR was positive for SARS-CoV-2 and negative for Herpesviridae viruses and mycobacterium tuberculosis. The patient was successfully treated with corticosteroid.Conclusion: We report a case of bilateral neuroretinitis and panuveitisin a recovered COVID-19 patient and positive RT-PCR of the vitreous sample. It is suggested to apply intraocular sampling and evaluation for COVID-19 in patients with the new-onset of uveitis and/or retinitis during the pandemic.


Subject(s)
COVID-19/complications , Eye Infections, Viral/etiology , Panuveitis/etiology , RNA, Viral/analysis , Retinitis/etiology , SARS-CoV-2/genetics , Visual Acuity , Adult , COVID-19/epidemiology , Eye Infections, Viral/diagnosis , Eye Infections, Viral/virology , Fluorescein Angiography/methods , Fundus Oculi , Humans , Male , Pandemics , Panuveitis/diagnosis , Panuveitis/virology , Retina/pathology , Retinitis/diagnosis , Retinitis/virology , Tomography, Optical Coherence/methods , Uvea/pathology
4.
Curr Eye Res ; 46(12): 1934-1935, 2021 12.
Article in English | MEDLINE | ID: covidwho-1116525

ABSTRACT

Ophthalmologic nvolvement in SARS-CoV-infected patients is variegated. One of the ophthalmologic pathologies is optic neuritis. Optic neuritis in SARS-CoV-infected patients may precede the classical pulmonary manifestations of COVID-19 and can be unilateral or bilateral. Optic neuritis has been repeatedly reported in COVID-19 patients and may occur with or without affection of other cranial nerves. Since cerebro-spinal fluid parameters can be abnormal in COVID-19 associated optic neuritis, these patients require a spinal tap. Before diagnosing SARS-CoV-2 associated optic neuritis various differentials need to be excluded. Since SARS-CoV-2 causes endothelial damage complicated by thrombus formation and thromboembolism, ophthalmologic vascular complication due to an infection with SARS-CoV-2 such as anterior ischemic optic neuropathy (AION), central retinal artery occlusion (CRAO), and retinal vein occlusion need to be excluded. CRAO may result from arterial hypertension, myocarditis, heart failure, Takotsubo syndrome, atrial fibrillation, or atrial flutter, frequent cardiac complications of COVID-19. Since CRAO can be accompanied by ischemic stroke, patients with SARS-CoV-2 associated optic neuritis need to undergo a cerebral MRI.


Subject(s)
COVID-19/complications , Eye Infections, Viral/diagnosis , Optic Neuritis/diagnosis , Retinal Diseases/diagnosis , Retinal Vessels/pathology , Retinitis/diagnosis , SARS-CoV-2 , Aged , Blindness/diagnosis , Blindness/virology , Diagnosis, Differential , Eye Infections, Viral/virology , Female , Humans , Optic Neuritis/virology , Retinal Diseases/virology , Retinal Vessels/virology , Retinitis/virology
5.
Curr Eye Res ; 46(8): 1247-1250, 2021 08.
Article in English | MEDLINE | ID: covidwho-1061052

ABSTRACT

OBJECTIVE: We documented an older female with Coronavirus(CoV) Disease 2019 (COVID-19) and concomitant acquired monocular blindness. We examined this phenomenon in order to understand COVID-19 better. METHODS: We observed an older female with COVID-19 and concomitant acquired monocular blindness. The following indicators were monitored during the course of the disease: ocular examinations, flash visual evoked potential examination, a blood test for COVID-19 IgM antibodies, as well as nasopharyngeal swab and tear sample tests for COVID-19 nucleic acid. RESULTS: The patient's visual acuity for the left eye was NLP and the intraocular pressure was 51 mmHg. Keratic precipitates similar to mutton-fat were spread over the corneal endothelium of the left eye. The funduscopic examination of the patient's left eye revealed severe retinal arterial ischemia, and the color of the retina was off-white. Compared to the right eye, the flash visual evoked potential examination revealed a moderate decrease in P2 wave amplitude for the left eye. A blood test was positive for COVID-19 IgM antibodies, and a nasopharyngeal swab test taken for COVID-19 nucleic acid was positive on May 4, 2020. A sample of the patient's tears was taken, and the nucleic acid test for COVID-19 was still positive two weeks later. CONCLUSIONS: Our study was the first to find that acute viral retinitis could occur in patients with COVID-19 and severe blindness could be associated with SARS-CoV-2 infection. Therefore, physicians should consider the possibility of coronavirus infection in patients with an abnormal fundus or suddenly vision loss.


Subject(s)
Blindness/diagnosis , COVID-19/diagnosis , Eye Infections, Viral/diagnosis , Retinitis/diagnosis , SARS-CoV-2/isolation & purification , Aged , Blindness/virology , COVID-19/virology , COVID-19 Nucleic Acid Testing , COVID-19 Serological Testing , Evoked Potentials, Visual/physiology , Eye Infections, Viral/virology , Female , Fluorescein Angiography , Humans , Immunoglobulin M/blood , Photic Stimulation , Retina/physiopathology , Retinitis/physiopathology , Retinitis/virology , SARS-CoV-2/genetics , SARS-CoV-2/immunology , Visual Acuity
SELECTION OF CITATIONS
SEARCH DETAIL